Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2006

View Archived Issues

PRX-00023 safe, induces prolactin release in healthy subjects

Rotigaptide safe, demonstrates predictable pharmacokinetics in healthy subjects

Sanochemia reports PVP-Hypericin progress

ACE BioSciences and Nordic Vaccine collaborate on vaccine development

Tetracyclines in dental research

Targeted chemotherapy with AN-215 in experimental prostate cancers yields positive results

Blockade of EGFR and IL-13 ceases progression towards asthma/bronchitis phenotype in mice

Efficacy and tolerability of fast-acting degarelix shown in patients with prostate cancer

Significant neutropenia seen with lenalidomide/docetaxel in patients with advanced solid tumors

Irinotecan drug-eluting beads studied for colorectal cancer metastases in the liver

Phase I/II study of L-annamycin for relapsed/refractory ALL adds new trial site

CytRx provides overview of recent developments in obesity and type 2 diabetes

Ad.SERCA2a gene therapy improves cardiac function in a large animal model of heart failure

Iomai receives award for pandemic flu research

Hana completes development of Zensana

Positive follow-up data from Multikine phase II study in head and neck cancer

FDA Advisory Committee votes against approval of Gemzar for ovarian cancer

Merck KGaA makes offer for Schering AG

Watson to acquire Andrx

FDA to consult Advisory Committee on proposed RESUS trial of Hemopure

ISIS-301012 does not interact with simvastatin or ezetimibe in study

AT-1001 completes phase Ib in celiac disease patients

Generic name pafuramidine maleate approved for Immtech's DB-289

BioMS to study MBP-8298 for relapsing-remitting MS

Long-term treatment benefits of Flurizan

Lipid subfractions, timing of doses studied with torcetrapib

TG-100-115 appears safe in STEMI patients undergoing PCI

Fast track designation for PPI-0903

XenoPort initiates phase III for XP-13512 in RLS

Surface Logix begins phase I study for SLx-4090

Efficacy of GW-685698 in seasonal allergic rhinitis reported

Neurotech reports promising results of phase I NT-501 safety trial

Recent patents report novel agents for pain, migraine, etc.

Novel antiinfective agents disclosed in recent patent literature

Novel agents with potential for treatment of inflammatory disorders revealed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.